OCX Annual Retained Earnings
-$289.88 M
-$29.20 M-11.20%
31 December 2023
Summary:
As of January 23, 2025, OCX annual retained earnings is -$289.88 million, with the most recent change of -$29.20 million (-11.20%) on December 31, 2023. During the last 3 years, it has fallen by -$166.20 million (-134.38%). OCX annual retained earnings is now -2683.79% below its all-time high of -$10.41 million, reached on December 31, 2013.OCX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCX Quarterly Retained Earnings
-$317.03 M
-$13.49 M-4.45%
30 September 2024
Summary:
As of January 23, 2025, OCX quarterly retained earnings is -$317.03 million, with the most recent change of -$13.49 million (-4.45%) on September 30, 2024. Over the past year, it has dropped by -$44.56 million (-16.36%). OCX quarterly retained earnings is now -1958.76% below its all-time high of -$15.40 million, reached on December 31, 2014.OCX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -16.4% |
| 3 y3 years | -134.4% | -53.6% |
| 5 y5 years | -306.4% | -53.6% |
OCX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.4% | at low | -68.8% | at low |
| 5 y | 5-year | -209.2% | at low | -238.2% | at low |
| alltime | all time | -2683.8% | at low | -1958.8% | at low |
OncoCyte Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$317.03 M(+4.4%) |
| June 2024 | - | -$303.54 M(+1.5%) |
| Mar 2024 | - | -$299.00 M(+3.1%) |
| Dec 2023 | -$289.88 M(+11.2%) | -$289.88 M(+6.4%) |
| Sept 2023 | - | -$272.46 M(+2.4%) |
| June 2023 | - | -$265.98 M(+3.2%) |
| Mar 2023 | - | -$257.64 M(-1.2%) |
| Dec 2022 | -$260.68 M(+38.8%) | -$260.68 M(+20.9%) |
| Sept 2022 | - | -$215.70 M(+4.5%) |
| June 2022 | - | -$206.44 M(+4.2%) |
| Mar 2022 | - | -$198.06 M(+5.5%) |
| Dec 2021 | -$187.77 M(+51.8%) | -$187.77 M(+23.6%) |
| Sept 2021 | - | -$151.89 M(+10.0%) |
| June 2021 | - | -$138.09 M(+8.2%) |
| Mar 2021 | - | -$127.60 M(+3.2%) |
| Dec 2020 | -$123.68 M(+31.9%) | -$123.68 M(+5.4%) |
| Sept 2020 | - | -$117.37 M(+6.1%) |
| June 2020 | - | -$110.58 M(+9.0%) |
| Mar 2020 | - | -$101.48 M(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -$93.75 M(+31.4%) | -$93.75 M(+9.3%) |
| Sept 2019 | - | -$85.79 M(+6.5%) |
| June 2019 | - | -$80.57 M(+7.2%) |
| Mar 2019 | - | -$75.18 M(+5.4%) |
| Dec 2018 | -$71.32 M(+30.4%) | -$71.32 M(+6.7%) |
| Sept 2018 | - | -$66.82 M(+4.7%) |
| June 2018 | - | -$63.85 M(+7.6%) |
| Mar 2018 | - | -$59.34 M(+8.5%) |
| Dec 2017 | -$54.68 M(+54.9%) | -$54.68 M(+7.8%) |
| Sept 2017 | - | -$50.72 M(+15.8%) |
| June 2017 | - | -$43.81 M(+9.5%) |
| Mar 2017 | - | -$40.01 M(+13.3%) |
| Dec 2016 | -$35.30 M(+46.3%) | -$35.30 M(+9.6%) |
| Sept 2016 | - | -$32.20 M(+8.8%) |
| June 2016 | - | -$29.61 M(+9.4%) |
| Mar 2016 | - | -$27.06 M(+12.1%) |
| Dec 2015 | -$24.13 M(+56.7%) | -$24.13 M(+17.2%) |
| Sept 2015 | - | -$20.59 M(+33.7%) |
| Dec 2014 | -$15.40 M(+47.9%) | -$15.40 M |
| Dec 2013 | -$10.41 M | - |
FAQ
- What is OncoCyte annual retained earnings?
- What is the all time high annual retained earnings for OncoCyte?
- What is OncoCyte annual retained earnings year-on-year change?
- What is OncoCyte quarterly retained earnings?
- What is the all time high quarterly retained earnings for OncoCyte?
- What is OncoCyte quarterly retained earnings year-on-year change?
What is OncoCyte annual retained earnings?
The current annual retained earnings of OCX is -$289.88 M
What is the all time high annual retained earnings for OncoCyte?
OncoCyte all-time high annual retained earnings is -$10.41 M
What is OncoCyte annual retained earnings year-on-year change?
Over the past year, OCX annual retained earnings has changed by -$29.20 M (-11.20%)
What is OncoCyte quarterly retained earnings?
The current quarterly retained earnings of OCX is -$317.03 M
What is the all time high quarterly retained earnings for OncoCyte?
OncoCyte all-time high quarterly retained earnings is -$15.40 M
What is OncoCyte quarterly retained earnings year-on-year change?
Over the past year, OCX quarterly retained earnings has changed by -$44.56 M (-16.36%)